{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:43:13Z","timestamp":1772520193669,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Adult Polyglucosan Body Disease (APBD) is a rare, autosomal recessive neurodegenerative disorder that affects both the central and peripheral nervous systems. It is primarily caused by mutations in the Glycogen Branching Enzyme 1 (<jats:italic>GBE<\/jats:italic>1) gene. APBD is typically associated with Ashkenazi Jewish populations, though it can occur in other ethnic groups. This study aims to expand the phenotypic and genetic spectrum of APBD, particularly in non-Ashkenazi Jewish patients, and to identify atypical genetic alterations linked to the disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A 57-year-old Chinese male (\u21613) presented with a 4-year history of progressive bladder dysfunction, upper and lower motor neuron impairment, sensory loss, and lower limb weakness, leading to difficulty with gait. Genetic testing was performed to identify potential pathogenic variants in the <jats:italic>GBE<\/jats:italic>1 gene. A family assessment revealed a sister (\u21615) with the same clinical features. Both patients underwent genetic analysis, which included sequencing and deletion analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Genetic testing revealed that both affected individuals (\u21613 and \u21615) carried compound heterozygous variants in the <jats:italic>GBE<\/jats:italic>1 gene: c.466C&amp;gt;T (p.R156C) in exon 4 and a large deletion of exons 3\u20137. The two pathogenic variants co-segregated in the family, confirming the diagnosis of APBD in these individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This case expands the phenotypic and genetic spectrum of APBD, particularly by documenting its occurrence in non-Ashkenazi Jewish patients. Additionally, the identification of atypical genetic alterations, such as the large deletion in <jats:italic>GBE<\/jats:italic>1, provides new insights into the genetic basis of the disease and may aid in understanding its broader clinical manifestations. These findings suggest the need for a broader genetic screening approach in APBD diagnosis, especially in diverse populations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgene.2025.1514610","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T07:08:30Z","timestamp":1742368110000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical genetic analysis of an adult polyglucosan body disease (APBD) family caused by the compound heterozygous variant of GBE1 p.R156C and deletion exon 3-7"],"prefix":"10.3389","volume":"16","author":[{"given":"Juan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Qi","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Zhu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Jun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Kui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamaneurol.2014.4496","article-title":"Deep intronic GBE1 mutation in manifesting heterozygous patients with adult polyglucosan body disease","volume":"72","author":"Akman","year":"2015","journal-title":"JAMA Neurol."},{"key":"B2","article-title":"GBE1 adult polyglucosan body disease","volume-title":"GeneReviews(R)","author":"Akman","year":"1993"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1212\/01.wnl.0000138429.11433.0d","article-title":"Clinical and genetic heterogeneity of branching enzyme deficiency (glycogenosis type IV)","volume":"63","author":"Bruno","year":"2004","journal-title":"Neurology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1007\/s10072-021-05096-3","article-title":"Adult polyglucosan body disease-an atypical compound heterozygous with a novel GBE1 mutation","volume":"42","author":"Carvalho","year":"2021","journal-title":"Neurol. Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"101140","DOI":"10.1016\/j.gendis.2023.101140","article-title":"Clinical and genetic heterogeneity of adult polyglucosan body disease caused by GBE1 biallelic mutations in China","volume":"11","author":"Chen","year":"2024","journal-title":"Genes Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s13311-021-01040-7","article-title":"Targeting Gys1 with AAV-SaCas9 decreases pathogenic polyglucosan bodies and neuroinflammation in adult polyglucosan body and lafora disease mouse models","volume":"18","author":"Gumusgoz","year":"2021","journal-title":"Neurotherapeutics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s13311-022-01218-7","article-title":"AAV-mediated artificial miRNA reduces pathogenic polyglucosan bodies and neuroinflammation in adult polyglucosan body and lafora disease mouse models","volume":"19","author":"Gumusgoz","year":"2022","journal-title":"Neurotherapeutics"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1007\/s00415-015-7859-4","article-title":"Frequent misdiagnosis of adult polyglucosan body disease","volume":"262","author":"Hellmann","year":"2015","journal-title":"J. Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e14554","DOI":"10.15252\/emmm.202114554","article-title":"Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism","volume":"13","author":"Kakhlon","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/mus.10520","article-title":"Adult polyglucosan body disease: case description of an expanding genetic and clinical syndrome","volume":"29","author":"Klein","year":"2004","journal-title":"Muscle Nerve"},{"key":"B11","doi-asserted-by":"publisher","first-page":"107525","DOI":"10.1016\/j.ymgme.2023.107525","article-title":"Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: a clinical practice resource","volume":"138","author":"Koch","year":"2023","journal-title":"Mol. Genet. Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jimd.12654","article-title":"Gene therapy for glycogen storage diseases","volume":"47","author":"Koeberl","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/0883073811415107","article-title":"Association of the congenital neuromuscular form of glycogen storage disease type IV with a large deletion and recurrent frameshift mutation","volume":"27","author":"Li","year":"2012","journal-title":"J. Child. Neurol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/ana.410440604","article-title":"Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene","volume":"44","author":"Lossos","year":"1998","journal-title":"Ann. Neurol."},{"key":"B15","first-page":"604","article-title":"Systemic-pulmonary shunt with autologous internal jugular vein","volume":"45","author":"Martinez Corrales","year":"1992","journal-title":"Rev. Esp. Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1442-200x.2004.01916.x","article-title":"Congenital form of glycogen storage disease type IV: a case report and a review of the literature","volume":"46","author":"Maruyama","year":"2004","journal-title":"Pediatr. Int."},{"key":"B17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/mus.20916","article-title":"Adult polyglucosan body disease: proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene","volume":"37","author":"Massa","year":"2008","journal-title":"Muscle Nerve"},{"key":"B18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/ana.23598","article-title":"Adult polyglucosan body disease: natural history and key magnetic resonance imaging findings","volume":"72","author":"Mochel","year":"2012","journal-title":"Ann. Neurol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamaneurol.2013.4888","article-title":"Branching enzyme deficiency: expanding the clinical spectrum","volume":"71","author":"Paradas","year":"2014","journal-title":"JAMA Neurol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/BF00334454","article-title":"Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis)","volume":"85","author":"Schroder","year":"1993","journal-title":"Acta Neuropathol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/jimd.12325","article-title":"GBE1-related disorders: adult polyglucosan body disease and its neuromuscular phenotypes","volume":"44","author":"Souza","year":"2021","journal-title":"J. Inherit. Metab. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/mus.20384","article-title":"Adult polyglucosan body disease: a case report of a manifesting heterozygote","volume":"32","author":"Ubogu","year":"2005","journal-title":"Muscle Nerve"},{"key":"B24","first-page":"126","article-title":"General practitioners' views on geriatric day hospital care","volume":"41","author":"Williams","year":"1991","journal-title":"Br. J. Gen. Pract."},{"key":"B25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ymgmr.2016.09.008","article-title":"Alglucosidase alfa treatment alleviates liver disease in a mouse model of glycogen storage disease type IV","volume":"9","author":"Yi","year":"2016","journal-title":"Mol. Genet. Metab. Rep."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1514610\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T07:08:32Z","timestamp":1742368112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1514610\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":25,"alternative-id":["10.3389\/fgene.2025.1514610"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1514610","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"article-number":"1514610"}}